SEC Pharma
+44(0)20 7255 6600
+33 (0)17 0807 489
+49 (0)69 2222 2888
+41 (0)44 5803 717
Click on the pad to see jobs
Biometrics
Clinical Research & Development
Drug Safety & Pharmacovigilance
Healthcare & Hospitals
HEOR & Market Access
HEOR & Market Access jobs
all job categories
    Currently we are not recruiting for any roles in this category.
    Medical Affairs & Communications
    Pharma IT
    Pharma IT jobs
    all job categories
      Currently we are not recruiting for any roles in this category.
      QA & QC
      Regulatory Affairs
      Sales, Business Development & Marketing
      Scientific, Engineering & Manufacturing

      quick job search

      All Permanent Contract

      Pharmaceutical Recruitment

      Whether its working with Pharmaceutical, CRO or Biotech organisations, within the disciplines of Clinical Development, Operations & Outsourcing, Regulatory Affairs, Biometrics, Healthcare, Drug Safety, R&D, Medical Affairs & Communications, QA/QC, Manufacturing & Engineering or Health Economics, SEC Pharma can assist wherever you are looking to hire or work throughout the UK and Europe.

      Established in 1995, SEC Pharma consists of a team of European, multi-lingual and highly experienced consultants who each have a background in clinical or scientific disciplines and know their markets extremely well. Our consultants work from two shared hub offices in London and Woking in the UK, however each one has a focus on a particular skill set and specific geography, depending on their technical knowledge, cultural awareness and language skills.

      By familiarising ourselves with individual candidate skill sets and personalities, as well as our client’s specific business requirements and cultures, we guarantee we can match jobseekers with client roles – ensuring both organisation and individual can work to their full potential, wherever they are located. We have successfully recruited in Belgium, UK, Netherlands, France, Germany, Switzerland, Spain, Italy, Poland, Denmark, Sweden and Norway.

      SEC latest news

      Social media updates

      SEC Analytics SEC Analytics SEC Analytics